Result of Placing

SkinBioTherapeutics plc (AIM: SBTX or the "Company") a life sciences company focused on skin health, is pleased to announce that, further to the announcement made on 16 November 2023 regarding the Placing (the "Launch Announcement"), it has raised £3.0 million (before expenses) via the placing of 15,908,298 Placing Shares at the Issue Price of 19 pence per share. The Placing was undertaken through an accelerated bookbuild and was materially oversubscribed.

The Placing Shares will, when issued, represent, in aggregate, circa 9.2 per cent. of the Company's issued ordinary share capital immediately prior to the Placing.

The Placing Price of 19 pence per Placing Share represents a 9.5 per cent. discount to the closing middle market price of 21 pence per Ordinary Share on 15 November 2023, being the last practicable dealing date prior to the publication of the Launch Announcement.

A further announcement will be made on 21 November 2023 announcing the result of the Retail Offer.

Application for Admission to Trading

Application has been made for the Placing Shares to be admitted to trading on AIM ("Admission"). It is expected that Admission will take place on or before 8.00 a.m. on 22 November 2023 and that dealings in the Placing Shares on AIM will commence at the same time.